Abstract
Alloimmunization to platelets frequently occurs in multitransfused patients and represents a major problem in platelet supportive therapy [1,2]. The provision of compatible platelets for alloimmunized patients remain difficult for the blood bank. Compatible platelet donors are usually selected based on HLA-compatibility between donor and recipient. Drawbacks of this approach are: a) a large HLA-typed donor panel is required that needs continuously updating and is therefore very expensive; 2) a significant percentage (13–31%) of HLA-matched platelet transfusions does not result in satisfactory posttransfusion platelet increments [3–61].
Supported by a grant from the Josephine Nefkens Foundation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tejada F, Bias WB, Santos GW, Zieve PD. Immunologic respons of patients with acute leukemia to platelet transfusions. Blood 1973;42:405–12.
Dutcher JP, Schiffer CA, Aisner J, Wiernik PH. Alloimmunization following platelet transfusion: The absence of a dose-response relationship. Blood 1981;57: 395–8.
Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH. Successful transfusion of platelets ‘mismatched’ for HLA antigens to alloimmunized thrombocytopenic patients. Am J Haemat 1977;2:219–26.
Brand A, van Leeuwen A, Eernisse JG, van Rood JJ. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Blood 1978;51:781–8.
Pegels J, Bruynes E, Engelfriet C, von dem Borne AEG Kr. Serological studies in patients on platelet- and granulocyte-substitution therapy. Br J Haemat 1982; 52:59–68.
Bonacossa IA, Perchotte M-RY, Olchowecki JK, Schroeder ML. Role of lymphocytotoxicity and Staph-Protein A assays in platelet donor selection. Curr Stud Haematol Blood Transf 1986;52:58–64.
Sintnicolaas K, van der Steuyt KJB, van Putten WLJ, Bolhuis RLH. A micro-plate ELISA for the detection of platelet alloantibodies; comparison with the platelet immunofluorescence test. Br J Haemat 1987;66:363–7.
van der Velden KJ, Sintnicolaas K, Löwenberg B. The value of a 51Cr platelet lysis assay as cross-match test in patients with leukemia on platelet transfusion therapy. Br J Haemat 1986;62:635–40.
Freedman J, Hooi C, Garbey MB. Prospective platelet cross-matching for selection of compatible random donors. Br J Haemat 1984;56:9–18.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Sintnicolaas, K., Sizoo, W., Bolhuis, R.L.H. (1987). Prospective Selection of Compatible Platelet Donors for Alloimmunized Patients by an ELISA Platelet Cross-Match Only. In: Sibinga, C.T.S., Das, P.C., Engelfriet, C.P. (eds) White cells and platelets in blood transfusion. Developments in Hematology and Immunology, vol 19. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2089-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2089-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9238-8
Online ISBN: 978-1-4613-2089-0
eBook Packages: Springer Book Archive